Cidara Therapeutics Inc
F:20D0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cidara Therapeutics Inc
F:20D0
|
US |
|
Schoeller Bleckmann Oilfield Equipment AG
OTC:SBOEF
|
AT |
|
T
|
Teck Resources Ltd
SWB:TPT
|
CA |
|
Eenergy Group PLC
F:A1Z1
|
UK |
|
TBS Holdings Inc
OTC:TKOBF
|
JP |
|
A
|
Aurubis AG
F:NDA
|
DE |
|
G
|
George Weston Ltd
OTC:WNGRF
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 20D0's stock price target?
Not Available
20D0 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Cidara Therapeutics Inc?
Projected CAGR
318%
The compound annual growth rate for Revenue over the next 4 years is 318%.